共 50 条
- [41] Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2017, 10 : 47 - 55
- [42] Cardiovascular risk factors in patients with diabetes mellitus JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, 1999, 18 (2-3): : 107 - 112
- [43] Reducing cardiovascular risk in patients with type 2 diabetes mellitus EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2010, 17 : S1 - S1